Gerd Mürtz

811 total citations
22 papers, 578 citations indexed

About

Gerd Mürtz is a scholar working on Urology, Rheumatology and Epidemiology. According to data from OpenAlex, Gerd Mürtz has authored 22 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Urology, 14 papers in Rheumatology and 5 papers in Epidemiology. Recurrent topics in Gerd Mürtz's work include Urinary Bladder and Prostate Research (17 papers), Pelvic floor disorders treatments (12 papers) and Urological Disorders and Treatments (6 papers). Gerd Mürtz is often cited by papers focused on Urinary Bladder and Prostate Research (17 papers), Pelvic floor disorders treatments (12 papers) and Urological Disorders and Treatments (6 papers). Gerd Mürtz collaborates with scholars based in Germany, Austria and United States. Gerd Mürtz's co-authors include M. Stöhrer, H. Madersbacher, Ralph Richter, H. Burgdörfer, H J Hachen, G. Krämer, J J Wyndaele, Gerhard Strugala, E. P. Arnold and Bruno Giannetti and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Urology and European Urology.

In The Last Decade

Gerd Mürtz

21 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerd Mürtz Germany 13 535 444 275 40 36 22 578
J J Wyndaele Belgium 11 463 0.9× 373 0.8× 189 0.7× 58 1.4× 18 0.5× 16 520
Gerhard Compion United Kingdom 8 455 0.9× 389 0.9× 266 1.0× 81 2.0× 21 0.6× 16 593
David Sussman United States 10 358 0.7× 294 0.7× 169 0.6× 63 1.6× 11 0.3× 25 440
H. Burgdörfer Germany 7 522 1.0× 423 1.0× 144 0.5× 64 1.6× 23 0.6× 13 579
Philip E.V.A. van Kerrebroeck Netherlands 11 437 0.8× 364 0.8× 150 0.5× 136 3.4× 16 0.4× 15 524
Joseph T. Wang United States 16 699 1.3× 562 1.3× 329 1.2× 128 3.2× 38 1.1× 22 753
BRIAN A. FEAGINS United States 6 397 0.7× 362 0.8× 106 0.4× 82 2.0× 8 0.2× 8 462
M. Wooning Netherlands 7 462 0.9× 340 0.8× 258 0.9× 80 2.0× 15 0.4× 8 499
David Mitcheson United States 7 610 1.1× 468 1.1× 364 1.3× 98 2.5× 22 0.6× 10 668
Lukas K. Daha Austria 9 857 1.6× 578 1.3× 421 1.5× 118 3.0× 9 0.3× 15 953

Countries citing papers authored by Gerd Mürtz

Since Specialization
Citations

This map shows the geographic impact of Gerd Mürtz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerd Mürtz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerd Mürtz more than expected).

Fields of papers citing papers by Gerd Mürtz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerd Mürtz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerd Mürtz. The network helps show where Gerd Mürtz may publish in the future.

Co-authorship network of co-authors of Gerd Mürtz

This figure shows the co-authorship network connecting the top 25 collaborators of Gerd Mürtz. A scholar is included among the top collaborators of Gerd Mürtz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerd Mürtz. Gerd Mürtz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stöhrer, M., Gerd Mürtz, G. Krämer, et al.. (2013). Efficacy and tolerability of propiverine hydrochloride extended-release compared with immediate-release in patients with neurogenic detrusor overactivity. Spinal Cord. 51(5). 419–423. 15 indexed citations
2.
Madersbacher, H., Gerd Mürtz, & M. Stöhrer. (2013). Neurogenic detrusor overactivity in adults: a review on efficacy, tolerability and safety of oral antimuscarinics. Spinal Cord. 51(6). 432–441. 49 indexed citations
3.
Schulte‐Baukloh, Heinrich, Gerd Mürtz, Paul F. Austin, et al.. (2011). Urodynamic effects of propiverine in children and adolescents with neurogenic bladder: Results of a prospective long-term study. Journal of Pediatric Urology. 8(4). 386–392. 11 indexed citations
4.
Alloussi, S., et al.. (2010). ANTIMUSCARINICS IN CHILDREN: IS ITS USE IN CHILDREN EVIDENCE-BASED?. Neurourology and Urodynamics.
5.
Siegmund, Werner, et al.. (2010). Pharmacokinetics and Pharmacodynamics of Propiverine in Children Aged between 5 and 10 Years with Symptoms of Overactive Bladder. Clinical Pharmacokinetics. 49(5). 335–342. 5 indexed citations
6.
Alloussi, S., Gerd Mürtz, C. Lang, et al.. (2010). Desmopressin treatment regimens in monosymptomatic and nonmonosymptomatic enuresis: A review from a clinical perspective. Journal of Pediatric Urology. 7(1). 10–20. 31 indexed citations
7.
Madersbacher, H., Gerd Mürtz, Thomas Henne, et al.. (2009). Propiverine vs oxybutynin for treating neurogenic detrusor overactivity in children and adolescents: results of a multicentre observational cohort study. British Journal of Urology. 103(6). 776–781. 26 indexed citations
8.
9.
Alloussi, S., et al.. (2008). Failure of monotherapy in primary monosymptomatic enuresis: a combined desmopressin and propiverine treatment regimen improves efficacy outcomes. British Journal of Urology. 103(12). 1706–1712. 14 indexed citations
10.
11.
Schulte‐Baukloh, Heinrich, et al.. (2006). Urodynamic effects of propiverine hydrochloride in children with neurogenic detrusor overactivity: a prospective analysis. British Journal of Urology. 97(2). 355–358. 16 indexed citations
12.
13.
Jünemann, Klaus‐Peter, et al.. (2005). Propiverine versus Tolterodine: Efficacy and Tolerability in Patients with Overactive Bladder. European Urology. 48(3). 478–482. 38 indexed citations
14.
Mürtz, Gerd, et al.. (2004). AN EMPIRICAL TREATMENT ALGORITHM FOR INCONTINENT CHILDREN. The Journal of Urology. 171(6 Part 2). 2667–2671. 6 indexed citations
15.
Alloussi, S., B. Schönberger, Gerd Mürtz, Gerhard Schubert, & Joachim Siegert. (2000). Behandlung des Urge-Syndroms mit Propiverin in der therapeutischen Praxis. Der Urologe B. 40(4). 367–373. 10 indexed citations
16.
Madersbacher, H., M. Stöhrer, Ralph Richter, et al.. (1995). Trospium chloride versus oxybutynin: a randomized, double‐blind, multicentre trial in the treatment of detrusor hyper‐reflexia. British Journal of Urology. 75(4). 452–456. 119 indexed citations
17.
Mürtz, Gerd, et al.. (1993). Safety and tolerance of trospium chloride in the high dose range.. PubMed. 43(4). 461–4. 19 indexed citations
18.
Matzkies, F, et al.. (1992). Ultrasound studies of the effect of trospium chloride on gall-bladder kinetics.. PubMed. 42(12). 1456–8. 3 indexed citations
19.
Stöhrer, M., Pierre Bauër, Bruno Giannetti, et al.. (1991). Effect of Trospium Chloride on Urodynamic Parameters in Patients with Detrusor Hyperreflexia due to Spinal Cord Injuries. Urologia Internationalis. 47(3). 138–143. 69 indexed citations
20.
Madersbacher, H., et al.. (1991). [High-dose trospium chloride in therapy of detrusor hyperreflexia].. PubMed. 30(4). 260–3. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J J Wyndaele Breakdown of academic impact, for papers by Gerhard Compion Breakdown of academic impact, for papers by David Sussman Breakdown of academic impact, for papers by H. Burgdörfer Breakdown of academic impact, for papers by Philip E.V.A. van Kerrebroeck Breakdown of academic impact, for papers by Joseph T. Wang Breakdown of academic impact, for papers by BRIAN A. FEAGINS Breakdown of academic impact, for papers by M. Wooning Breakdown of academic impact, for papers by David Mitcheson Breakdown of academic impact, for papers by Lukas K. Daha
Rankless by CCL
2026